As the main enzyme that catalyzes adenosine production, CD73 is critical in inhibiting adequate anti-tumor immune responses, mainly through the production of adenosine, but also by promoting cancer cell proliferation, tumor growth, angiogenesis, and metastasis, warranting further study (Fig. 2). Here, NT5E is linked to cancer.